Do we really want to take it all the way Gassy ? Yes we get huge upside but for a small biotech ex Australia to make it all the way are few and far between - yes CSL of course but how many others have failed between where we are now and selling their product on the open market ?
Ideally we partner in some way early next year, this is when i see the re-rate happening. One thing is clear, our leverage in any future partnership has increased significantly with the cash in the bank
$15m cap raise Fresh Equities at 24c, page-628
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.001(1.27%) |
Mkt cap ! $84.79M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.1¢ | 7.9¢ | $87.18K | 1.091M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 554723 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 12.55pm 18/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |